Literature DB >> 9725626

Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality.

G T Mullenbach1, C Y Chiu, A Gyenes, J Blaney, S Rosenberg, C K Marlowe, S Brown, J Stratton-Thomas, G T Montelione, C George-Nascimento, G Stauber.   

Abstract

Six mutants of human epidermal growth factor (EGF), which carry single point substitutions within a surface patch proposed to juxtapose the bound receptor, were prepared and characterized for receptor affinity and mitogenicity. Receptor affinities relative to EGF are G12Q > H16D > Y13W > Q43A approximately = H16A approximately = EGF >> L15A. Notably, the reduced receptor affinity of mutant L15A indicates that Leu15 probably contributes substantially to receptor binding whereas unaltered receptor affinities observed for analogs H16A and Q43A indicate that neither His16 nor Gln43 contributes significantly to this interaction. On the other hand, the observed enhanced receptor affinities of analogs G12Q, Y13W and H16D highlight surface loci where additional productive receptor-binding contacts can be introduced. Interestingly, at acidic pH analog H16A reveals substantially greater receptor affinity than that of EGF, a property which may offer enhanced therapeutic utility in acidic environments in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725626     DOI: 10.1093/protein/11.6.473

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  2 in total

1.  Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation.

Authors:  Jennifer L Lahti; Bertrand H Lui; Stayce E Beck; Stephen S Lee; Daphne P Ly; Michael T Longaker; George P Yang; Jennifer R Cochran
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

2.  High-throughput de novo screening of receptor agonists with an automated single-cell analysis and isolation system.

Authors:  Nobuo Yoshimoto; Kenji Tatematsu; Masumi Iijima; Tomoaki Niimi; Andrés D Maturana; Ikuo Fujii; Akihiko Kondo; Katsuyuki Tanizawa; Shun'ichi Kuroda
Journal:  Sci Rep       Date:  2014-02-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.